$PHAT

$5.94 +$0.20 (3.48%) Close

$PHAT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$PHAT Management Team

Mr. Michael Cola

Independent Chairman of the Board

Age 65

Compensation $343.6K USD

Sex Male

Mr. Steven Basta

President

Chief Executive Officer

Director

Age 59

Compensation -

Sex Male

Dr. Azmi Nabulsi

Co-Founder

Chief Operating Officer

Age 65

Compensation $1.567M USD

Sex Male

Mr. Sanjeev Narula

Chief Financial and Business Officer

Age 65

Compensation -

Sex Male

Ms. Anne Cook

Chief Legal Officer and Corporate Secretary

Age 63

Compensation -

Sex Female

Name / Title	Age	Compensation	Sex
Mr. Michael Cola Independent Chairman of the Board	65	$343.6K USD	Male
Mr. Steven Basta President Chief Executive Officer Director	59	-	Male
Dr. Azmi Nabulsi Co-Founder Chief Operating Officer	65	$1.567M USD	Male
Mr. Sanjeev Narula Chief Financial and Business Officer	65	-	Male
Ms. Anne Cook Chief Legal Officer and Corporate Secretary	63	-	Female

Board of Directors

From the proxy statement filed Apr 7, 2026

Directors

serving now

Independent

7 of 7

stated in the proxy; 1 not stated

Average tenure

4.6 years

from year joined

CEO also chairs the board

Michael F. Cola

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Steven Basta CEO	60	2025 1 year	Not stated	None stated	VYNE Therapeutics, Inc.	Paid as CEO
Theodore R. Schroeder	71	2025 1 year	Independent	Audit Committee	None stated	$242,309
Mark Stenhouse	59	2020 6 years	Independent	Compensation Committee	None stated	$173,920
Michael F. Cola Board chair	66	2019 7 years	Independent	None stated	None stated	$224,753
Frank Karbe	57	2022 4 years	Independent	Audit Committee	None stated	$176,420
Asit Parikh, M.D., Ph.D.	54	2019 7 years	Independent	None stated	None stated	$182,253
Heidi Kunz	71	2019 7 years	Independent	None stated	None stated	$186,420
James Topper, M.D., Ph.D.	64	2022 4 years	Independent	Nominating and Corporate Governance Committee	NewAmsterdam Pharma B.V.	$169,753

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 7, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Comments

Company Executives

$PHAT Management Team

Mr. Michael Cola

Mr. Steven Basta

Dr. Azmi Nabulsi

Mr. Sanjeev Narula

Ms. Anne Cook

Board of Directors

Related-party transactions

No related-party transactions disclosed